The University of Chicago Header Logo

Connection

Lilly Immergluck to RNA, Messenger

This is a "connection" page, showing publications Lilly Immergluck has written about RNA, Messenger.
Connection Strength

0.038
  1. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.